Applied Genetics Technologies Corporation: Funding & Investors (Oct 2026)
Applied Genetics Technologies Corporation (AGTC) is creating treatments intended to change the existences of patients with serious infections, offering desire to patients with neglected clinical requirements. With a profoundly particular group of doctors and scientists, They utilize state of the art strategies to foster medicines for patients that have illnesses brought about by broken qualities. They use quality treatment, which replaces those messed up qualities with typical utilitarian qualities, permitting a patient's own body to create proteins to treat their sickness. A solitary infusion gives durable treatment, prompting a superior personal satisfaction for patients around the world.
Applied Genetics Technologies Corporation has raised $10.0M across 1 funding round on record, the most recent a Post-IPO Equity of $10.0M announced in Jul 2022.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Applied Genetics Technologies Corporation Company Profile and Key Stats
Latest funding round on record: Jul 2022.
Applied Genetics Technologies Corporation Funding Rounds
Applied Genetics Technologies Corporation Founders and Leadership Team
No contact details are on record for this team yet.
Applied Genetics Technologies Corporation Funding Compared to Other Biotechnology Startups
Applied Genetics Technologies Corporation's latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Applied Genetics Technologies Corporation in Biotechnology and Alachua
Companies Similar to Applied Genetics Technologies Corporation
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Applied Genetics Technologies Corporation Funding FAQs
What does Applied Genetics Technologies Corporation do?
Applied Genetics Technologies Corporation (AGTC) is creating treatments intended to change the existences of patients with serious infections, offering desire to patients with neglected clinical requirements. With a profoundly particular group of doctors and scientists, They utilize state of the art strategies to foster medicines for patients that have illnesses brought about by broken qualities. They use quality treatment, which replaces those messed up qualities with typical utilitarian qualities, permitting a patient's own body to create proteins to treat their sickness. A solitary infusion gives durable treatment, prompting a superior personal satisfaction for patients around the world.
How much funding has Applied Genetics Technologies Corporation raised?
Applied Genetics Technologies Corporation has raised $10.0M across 1 round on record. The most recent is a Post-IPO Equity of $10.0M announced in Jul 2022.
When did Applied Genetics Technologies Corporation last raise funding?
Applied Genetics Technologies Corporation's most recent funding round on record is a Post-IPO Equity of $10.0M, announced in Jul 2022.
Who founded Applied Genetics Technologies Corporation?
FundedIQ lists Terence Flotte (Founder) at Applied Genetics Technologies Corporation.
Where is Applied Genetics Technologies Corporation headquartered?
Applied Genetics Technologies Corporation is based in Alachua, Florida, United States.
How many employees does Applied Genetics Technologies Corporation have?
Applied Genetics Technologies Corporation is in the 11-50 employee band.
How does Applied Genetics Technologies Corporation's funding compare to other Biotechnology startups?
Applied Genetics Technologies Corporation's latest round of $10.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Applied Genetics Technologies Corporation Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Applied Genetics Technologies Corporation is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.